Search research articles
Contact Us
Filters
Showing results (151-160 of 168) with videos related to
Page
of 17
Sort By:
Cancer
|
December 22, 2017
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine
Verena Sailer, Marc H Schiffman, Myriam Kossai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2017
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Emmanuel S Antonarakis, Scott T Tagawa, Giuseppe Galletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran, Clara Oromendia, Daniel C Danila, et al.
Cancer Discovery
|
March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
Himisha Beltran, David S Rickman, Kyung Park, et al.
Nature Communications
|
July 7, 2019
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Brian D Robinson, Panagiotis J Vlachostergios, Bhavneet Bhinder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2021
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide
Landon C Brown, Susan Halabi, Joseph D Schonhoft, et al.
European Urology Oncology
|
June 10, 2025
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution
Himanshu Nagar, Marshall A Diven, Brady Rippon, et al.
Communications Medicine
|
January 12, 2026
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort
Majd Al Assaad, Kevin Hadi, Max F Levine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2019
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
Andrew J Armstrong, Susan Halabi, Jun Luo, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 168) with videos related to
Sort By:
Page
of 17
Cancer
|
December 22, 2017
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine
Verena Sailer, Marc H Schiffman, Myriam Kossai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 21, 2017
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Emmanuel S Antonarakis, Scott T Tagawa, Giuseppe Galletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 21, 2018
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Himisha Beltran, Clara Oromendia, Daniel C Danila, et al.
Cancer Discovery
|
March 6, 2012
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
Himisha Beltran, David S Rickman, Kyung Park, et al.
Nature Communications
|
July 7, 2019
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Brian D Robinson, Panagiotis J Vlachostergios, Bhavneet Bhinder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 6, 2021
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide
Landon C Brown, Susan Halabi, Joseph D Schonhoft, et al.
European Urology Oncology
|
June 10, 2025
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution
Himanshu Nagar, Marshall A Diven, Brady Rippon, et al.
Communications Medicine
|
January 12, 2026
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort
Majd Al Assaad, Kevin Hadi, Max F Levine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 14, 2019
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
Andrew J Armstrong, Susan Halabi, Jun Luo, et al.
Page
of 17